Ray Kerins News
-
Pfizer Inc., the world’s largest drugmaker, rose to its highest price in more than four years after Goldman Sachs Group Inc. analysts said the company may go beyond the divestiture plans it has already announced.
-
Pfizer Inc., the world’s biggest drugmaker, shuffled its executive leadership team and eliminated a layer of reporting structure following the naming of Ian Read to chief executive officer last week.
-
Pfizer Inc. , the world’s biggest drugmaker, named Ian C. Read chief executive officer as the company prepares to face generic competition to its top-selling cholesterol treatment Lipitor.
-
Pfizer Inc ., seeking to expand its growing international business, named David Simmons head of emerging markets, replacing Jean-Michel Halfon .
-
Judges on both sides of the Atlantic Ocean are moving toward a resolution of the legal dispute blocking the sale of Liverpool soccer club to the owners of baseball’s Boston Red Sox.
-
Drugmaker executives whose companies promote unauthorized uses of their medicines may be targeted by U.S. regulators for misdemeanor prosecutions, Food and Drug Administration Deputy Chief for Litigation Eric Blumberg said.
-
When U.S. House Republican leaders in 2003 were short of votes to pass a $395 billion Medicare prescription drug benefit, they recruited former House Speaker Newt Gingrich for help.
-
Jeffrey Kindler resigned as Pfizer Inc. ’s chief executive officer after he refused to name a head of operations as part of a plan agreed to by senior managers in September, said a person familiar with the proceedings.
-
Eli Lilly & Co. , under pressure to gain new products after setbacks this week with two diabetes drugs, may try to acquire its partner Amylin Pharmaceuticals Inc. or covet companies with more approved products.
-
Jeffrey Kindler ’s refusal to name an operations chief in response to a push from senior managers cost him his job as chief executive officer of Pfizer Inc., according to a person familiar with the process.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page